136 related articles for article (PubMed ID: 7505225)
41. The Urolume as a means of treating urinary outflow obstruction and its impact on waiting lists.
Schneider HJ; De Souza JV; Palmer JH
Br J Urol; 1994 Feb; 73(2):181-4. PubMed ID: 7510573
[TBL] [Abstract][Full Text] [Related]
42. Long-term outcome of prostatic stent treatment for benign prostatic hyperplasia.
Chiou RK; Chen WS; Akbari A; Foley S; Lynch B; Taylor RJ
Urology; 1996 Oct; 48(4):589-93. PubMed ID: 8886065
[TBL] [Abstract][Full Text] [Related]
43. The use of prostatic stents in patients with urinary retention who are unfit for surgery. An interim report.
McLoughlin J; Jager R; Abel PD; el Din A; Adam A; Williams G
Br J Urol; 1990 Jul; 66(1):66-70. PubMed ID: 1697492
[TBL] [Abstract][Full Text] [Related]
44. Urethral stent (Angiomed-Memotherm) implantation in high-risk patients with urinary retention.
Uchikoba T; Horiuchi K; Satoh M; Oka F; Saitoh Y; Tsuboi N; Nishimura T
Hinyokika Kiyo; 2005 Apr; 51(4):235-9. PubMed ID: 15912781
[TBL] [Abstract][Full Text] [Related]
45. Transurethral ethanol injection for prostatic obstruction: an excellent treatment strategy for persistent urinary retention.
Mutaguchi K; Matsubara A; Kajiwara M; Hanada M; Mizoguchi H; Ohara S; Yasumoto H; Usui T
Urology; 2006 Aug; 68(2):307-11. PubMed ID: 16904442
[TBL] [Abstract][Full Text] [Related]
46. Randomized controlled trial on the efficacy of bladder training before removing the indwelling urinary catheter in patients with acute urinary retention associated with benign prostatic hyperplasia.
Zhengyong Y; Changxiao H; Shibing Y; Caiwen W
Scand J Urol; 2014 Aug; 48(4):400-4. PubMed ID: 24697345
[TBL] [Abstract][Full Text] [Related]
47. A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia.
Cowles RS; Kabalin JN; Childs S; Lepor H; Dixon C; Stein B; Zabbo A
Urology; 1995 Aug; 46(2):155-60. PubMed ID: 7542818
[TBL] [Abstract][Full Text] [Related]
48. Intraurethral catheter in high-risk patients with urinary retention: 3 years of experience.
Sassine AM; Schulman CC
Eur Urol; 1994; 25(2):131-4. PubMed ID: 7511105
[TBL] [Abstract][Full Text] [Related]
49. [Long-term results of wall stent implantation in benign prostatic hyperplasia and high risk status].
Goepel M; Senge A; Otto T; Rübben H
Urologe A; 1997 Mar; 36(2):151-6. PubMed ID: 9199043
[TBL] [Abstract][Full Text] [Related]
50. A permanent, epithelializing stent for the treatment of benign prostatic hyperplasia. Preliminary results.
Oesterling JE
J Androl; 1991; 12(6):423-8. PubMed ID: 1722799
[TBL] [Abstract][Full Text] [Related]
51. Prostate stent is an option for selected patients who are unsuitable for transurethral resection of the prostate.
Skydsgaard Schou-Jensen K; Dahl C; Azawi NH
Dan Med J; 2014 Oct; 61(10):A4937. PubMed ID: 25283624
[TBL] [Abstract][Full Text] [Related]
52. Urodynamic impact of acute urinary retention in patients with benign prostatic hyperplasia: a 2-year follow-up after transurethral resection of the prostate.
Wagenlehner FM; Bescherer K; Wagenlehner C; Zellner M; Weidner W; Naber KG
Urol Int; 2011; 86(1):73-9. PubMed ID: 20689259
[TBL] [Abstract][Full Text] [Related]
53. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
[TBL] [Abstract][Full Text] [Related]
54. Durability of 30-minute high-energy transurethral microwave therapy for treatment of benign prostatic hyperplasia: a study of 213 patients with and without urinary retention.
Gravas S; Laguna P; Kiemeney LA; de la Rosette JJ
Urology; 2007 May; 69(5):854-8. PubMed ID: 17482921
[TBL] [Abstract][Full Text] [Related]
55. Stone incrustation: a relevant complication of the intraprostatic spiral.
Chiu AW; Lin AT; Lee YH; Chen MT; Chang LS
Eur Urol; 1991; 19(4):304-7. PubMed ID: 1717280
[TBL] [Abstract][Full Text] [Related]
56. A randomised study to evaluate the efficacy of a biodegradable stent in the prevention of postoperative urinary retention after interstitial laser coagulation of the prostate.
Pétas A; Isotalo T; Talja M; Tammela TL; Välimaa T; Törmälä P
Scand J Urol Nephrol; 2000 Aug; 34(4):262-6. PubMed ID: 11095085
[TBL] [Abstract][Full Text] [Related]
57. Epithelializing stent for benign prostatic hyperplasia: a systematic review of the literature.
Armitage JN; Cathcart PJ; Rashidian A; De Nigris E; Emberton M; van der Meulen JH
J Urol; 2007 May; 177(5):1619-24. PubMed ID: 17437773
[TBL] [Abstract][Full Text] [Related]
58. Urolume prostatic stents for urinary retention due to benign prostatic hyperplasia in patients with high medical risks.
Yip KH; Lee F; Lam PC; Ho KK
Hong Kong Med J; 1997 Jun; 3(2):136-140. PubMed ID: 11850562
[TBL] [Abstract][Full Text] [Related]
59. 3-Year follow-up of temporary implantable nitinol device implantation for the treatment of benign prostatic obstruction.
Porpiglia F; Fiori C; Bertolo R; Giordano A; Checcucci E; Garrou D; Cattaneo G; De Luca S; Amparore D
BJU Int; 2018 Jul; 122(1):106-112. PubMed ID: 29359881
[TBL] [Abstract][Full Text] [Related]
60. [Mesh-like tubular stent treatment for chronic urinary retention caused by benign prostatic hypertrophy].
Wang X; Zhu J; Hou S
Zhonghua Wai Ke Za Zhi; 1996 Feb; 34(2):107-9. PubMed ID: 9388336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
